跳至主要内容
临床试验/CTRI/2024/06/068459
CTRI/2024/06/068459尚未招募不适用

A randomized open-label controlled clinical study to evaluate the efficacy of Lodhra Arka Aschyotana in the management of Kaphaja Abhishyanda.

Dr Sharon K Manohar1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年6月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Significant improvement in the signs and symptoms of Kaphaja Abhishyanda.

研究概览

简要总结

Kaphaja Abhishyanda is a  Sadhya  Vyadhicharacterized bySrava, Guruta, Kandu, Shophaand*Upadeha.*Upon neglecting, it may lead to complications like *Kaphaja Adhimantha.*The signs and symptoms of Kaphaja Abhishyandacan be considered to different types of Conjunctivitis which is  broadly  classified into Allergic and Infective.In this present study, an effort will be done to evaluate comparative efficacy of Lodhra Arka Aschyotana in the management of Kaphaja Abhishyanda.

RESEARCH QUESTION:

Whether Lodhra Arka Aschyotanais effective in the management of Kaphaja Abhishyanda?

HYPOTHESES:

**Null Hypothesis (H0):**There is no significant difference in the efficacy of Lodhra Arka Aschyotana and Shigrupallava Arka Aschyotana in the management of Kaphaja Abhishyanda.

**Alternative Hypothesis (H1):**The efficacy of Lodhra Arka Aschyotana is better than Shigrupallava Arka Aschyotana in the management of Kaphaja Abhishyanda.

Alternative Hypothesis (H2): The efficacy of Shigrupallava Arka Aschyotana is better than Lodhra Arka Aschyotanain the management of Kaphaja Abhishyanda.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • 1.Subjects aged between 21-40 years irrespective of gender, occupation, religion and socio-economic status.
  • 2.Subjects fulfilling the diagnostic criteria.
  • 3.Subjects willing to undergo trial and sign the informed consent.

排除标准

  • 1.History of any intraocular surgery.
  • 2.Subject having any ocular trauma 3.Diagnosed cases of glaucoma.
  • 4.Subjects having any uncontrolled systemic illness that can interfere with the course of disease and treatment.
  • 5.Subjects suffering from an infective disease of the eye like Uveitis, Scleritis, Keratitis, Stye, Endophthalmitis, Blepharitis,Retinitis, Dacryocystitis.
  • 6.Pregnant and lactating women.

结局指标

主要结局

Significant improvement in the signs and symptoms of Kaphaja Abhishyanda.

时间窗: Pre assessment-0th day | Post assessment-8 th day | 1st follow up-15th day | 2nd follow up-30th day

次要结局

  • 1.Generation of in depth analysed data on the different aspect of the disease.(2.Generation of data on possible drug reaction.)

研究者

发起方
Dr Sharon K Manohar
申办方类型
Other [(self)]
责任方
Principal Investigator
主要研究者

SHARON K MANOHAR

Sri Sri College of Ayurvedic Science and Research Hospital

研究点 (1)

Loading locations...

相似试验